In the early days of the COVID-19 pandemic, Sanofi and Regeneron launched an ambitious plan to test rheumatoid arthritis with Kevzara in desperately ill patients. But after the first warning signs, a phase 3 failure has forced drug makers to make their judgment in the United States. Sanofi and Regeneron …
Read More »Sanofi, Regeneron closed the Kevzara trial on COVID-19 after finding no benefit for ventilated patients
